P2RX7 and glioma: Further studies corroborated that the P2X7 receptor acts synergistically with radiotherapy promoting cytotoxicity, and the level of P2X7 receptor expression is a good prognosis predictor for radiotherapy response in gliomas (Gehring et al., 2015).